AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Stock index values update on scheduled times or upon data arrivals, varying by index and exchange. This piece covers the timing and implications.
22,965 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Alphabet has overtaken its peers to become the most profitable U.S. tech giant as AI and cloud demand drive stronger ...
Investors are reassessing opportunities in firearm makers as policy shifts and demand cycles test the staying power o...
A wave of AI-generated wedding memes and rumors grabbed headlines, but the real lesson isn’t about celebrity gossip—i...
The bond market nearing threshold as long-term yields climb in a period of geopolitical tension and data surprises. T...
Broadcom is shifting from a broad tech portfolio to a focused AI chip powerhouse. If the company can turn custom AI c...
GM is rebooting its U.S. investment strategy with tighter budgets and sharper priorities. This move aims to boost nea...
In 2026, nuclear energy climbs back into the spotlight as AI-driven electricity demand surges. This article lays out ...
NVIDIA and SK Hynix unveil a sweeping memory collaboration that could steady Seoul’s wobbling stock market as AI infr...
Ford investors are watching for signs of real momentum beyond headlines. This article breaks down the latest little g...
Oracle reports a powerful cloud quarter and record backlog, signaling a potential future milestone. Yet mounting capi...
As AI spending hits record levels, Chamath Palihapitiya argues the real test is whether buyers of AI can deliver dura...